Q Biomed Inc (QBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 11-2017 | 11-2016 | 11-2015 | 11-2014 | 11-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,542 | -7,172 | -1,087 | -38 | -1 |
| Depreciation Amortization | 628 | 414 | 12 | N/A | N/A |
| Accounts payable and accrued liabilities | -34 | 439 | 90 | 1 | 1 |
| Other Working Capital | 32 | 576 | 90 | 1 | 1 |
| Other Operating Activity | 8,331 | 4,197 | 803 | -1 | -1 |
| Operating Cash Flow | $-5,585 | $-1,545 | $-91 | $-37 | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,500 | 2,645 | 210 | N/A | N/A |
| Common Stock Issued | 70 | 238 | N/A | 25 | 25 |
| Other Financing Activity | 2,371 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $4,941 | $2,883 | $210 | $25 | $25 |
| Beginning Cash Position | 1,469 | 131 | 13 | 25 | N/A |
| End Cash Position | 825 | 1,469 | 131 | 13 | 25 |
| Net Cash Flow | $-644 | $1,337 | $119 | $-12 | $25 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,585 | -1,545 | -91 | -37 | N/A |
| Free Cash Flow | -5,585 | -1,545 | -91 | -37 | 0 |